Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Strong Sell

Analyst Rating

Strong Sell

Simple Moving Average

Buy

Exponential Moving Average

Buy

Relative Strength Index

Neutral

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Buy

Wall Street Data Solutions Rating

Neutral

B

ARS Pharmaceuticals, Inc. Common Stock (SPRY)

Pharmaceutical Preparations

https://www.ars-pharma.com

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy (previously referred to as ARS-1) for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

11682 EL CAMINO REAL, SUITE 120
SAN DIEGO, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

11/09/2022

Market Cap

1,312,589,264

Shares Outstanding

96,000,000

Weighted SO

95,997,252

Total Employees

N/A

Upcoming Earnings

08/08/2024

Beta

0.7724

Last Div

0.0000

Range

2.55-13.718

Chg

0.0050

Avg Vol

789908

Mkt Cap

1312589264

Exch

NASDAQ

Country

US

Phone

858 335 1300

DCF Diff

12.7976

DCF

0.7424

Div Yield

0.0000

P/S

2792.7431

EV Multiple

-22.5010

P/FV

6.0911

Div Yield %

0.0000

P/E

-29.2494

PEG

-0.8879

Payout

0.0000

Current Ratio

32.7787

Quick Ratio

32.7787

Cash Ratio

5.4462

DSO

438.0000

DIO

0.0000

Op Cycle

438.0000

DPO

19262.5806

CCC

-18824.5806

Gross Margin

0.8681

Op Margin

-120.7149

Pretax Margin

-95.3681

Net Margin

-95.3681

Eff Tax Rate

-0.0834

ROA

-0.2019

ROE

-0.1976

ROCE

-0.2636

NI/EBT

1.0000

EBT/EBIT

0.7900

EBIT/Rev

-120.7149

Debt Ratio

0.0007

D/E

0.0007

LT Debt/Cap

0.0000

Total Debt/Cap

0.0007

Int Coverage

-15.1215

CF/Debt

-275.9813

Equity Multi

1.0312

Rec Turnover

0.8333

Pay Turnover

0.0189

Inv Turnover

0.0000

FA Turnover

0.6010

Asset Turnover

0.0021

OCF/Share

-0.4560

FCF/Share

-0.4568

Cash/Share

2.2591

OCF/Sales

-93.9511

FCF/OCF

1.0017

CF Coverage

-275.9813

ST Coverage

-275.9813

CapEx Coverage

-604.8904

Div&CapEx Cov

-604.8904

P/BV

6.0911

P/B

6.0911

P/S

2792.7431

P/E

-29.2494

P/FCF

-29.6764

P/OCF

-29.6906

P/CF

-29.6906

PEG

-0.8879

P/S

2792.7431

EV Multiple

-22.5010

P/FV

6.0911

DPS

0.0000

Latest Headlines (EST)

Revenue Product Segmentation